Rep. Kim Hyeong-dong Introduces Amendment to Narcotics Control Act as Primary Sponsor — Classifies CBD as Psychotropic Pharmaceutical, Establishes Basis for Domestic Manufacture

Rep. Kim Hyeong-dong (People Power Party) has introduced, as the primary sponsor, an amendment to the Narcotics Control Act to classify hemp-derived components with proven medical efficacy, such as CBD, as psychotropic pharmaceuticals and permit domestic manufacturing and product approvals. The bill also includes measures to support hemp industrialization in Andong and proposes establishing a state-led Medical Narcotics Raw Materials Management Center to create a tightly controlled system from cultivation through manufacture.

For the full article, please visit the original source link below. CannabisInsight curates and summarizes key news from the global cannabis and hemp industry.